Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Use of Rasch analysis to refine a patient-reported questionnaire on satisfaction with communication of the multiple sclerosis diagnosis.
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis.
Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Spinocerebellar Ataxias Type 8, 12, and 17 and Dentatorubro-Pallidoluysian Atrophy in Czech Ataxic Patients.
Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus.
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Cognition and eye movements: assessment of cerebral dysfunction.
Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Extended interval dosing of natalizumab: a two-center, 7-year experience.
Evidence linking HHV-6 with multiple sclerosis: an update.
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale.

Pages